Back

Assessment of reverse remodeling after transcatheter aortic valve replacement in the presence of established right ventricular damage

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Interdependence of value and myocardial disease Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Sara Cristina Peralta Merelo

San Carlos Clinical Hospital, Madrid (Spain)

7 More presentations in this session

Presentation thumbnail
Pressure-volume-strain-derived myocardial work: a novel prognostic marker in patients undergoing transcatheter aortic valve replacement
Doctor T. Turschl (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Incidence and prognostic impact of periprocedural myocardial injury during transcatheter aortic valve implantation
Doctor L. Waldschmidt (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Impact of cardiac reverse remodeling on prognosis after transcatheter aortic valve replacement in patients with mixed aortic valve disease
Doctor Y. Saijo (Tokushima, JP)
Abstract Slides Video
Presentation thumbnail
Cardiac damage and outcome in transcatheter aortic valve replacement patients
Mr R. Carter-Storch (Odense, DK)
Abstract Slides Video
Presentation thumbnail
Elevated preprocedural CT-ECV predicts residual LV morphological and functional impairment after TAVI
Doctor K. Terasaka (Yokohama, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Interdependence of value and myocardial disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Is relative aortic valve load determinant of left ventricular remodeling in patients with severe aortic stenosis referred for surgical valve replacement?
thumbnail
Congress Presentation
Impact of cardiac reverse remodeling on prognosis after transcatheter aortic valve replacement in patients with mixed aortic valve disease
thumbnail
Congress Presentation
Impact of the annulus -to-prosthesis size ratio on reverse cardiac remodeling in patients undergoing TAVR

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources